Publications & Works

Publication Network
Articles 11
All (11)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (7)
ESCI (3)
Scopus (6)
TRDizin (4)
Other Publications (1)

1. Impact of EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) on optimal antimicrobial therapy in gram-negative bloodstream infections

ÖZGEN TOP Ö., ÇİFCİ B., BÜYÜKKÖRÜK M., Can H., AYSERT YILDIZ P., MARTLI H. F., et al.
INFECTIOUS DISEASES NOW , vol.54, no.8, 2024 (SCI-Expanded) identifier identifier identifier

2. Healthcare-associated Candidemia Rate in COVID 19 Patients in Intensive Care Unit: A Retrospective Analysis of Infection Control Committee Records

Muftah H., ERGANİŞ S., ŞAHİN E. A., ÖZTÜRK E., Demir F., BÜYÜKKÖRÜK M., et al.
Türk Mikrobiyoloji Cemiyeti Dergisi , vol.54, 2024 (Peer-Reviewed Journal)

3. Evaluating the frequency and risk factors of multidrug-resistant bacteria in biliary samples

YILDIZ M., BÜYÜKKÖRÜK M., ARSLAN Ş., GÖKALP U., BOSTANCI H., DİKMEN K., et al.
Iranian Journal of Microbiology , vol.16, no.4, pp.484-489, 2024 (ESCI) identifier identifier

4. The Effect of Prophylactic Carbapenem Use on Outcomes in Acute Pancreatitis: A Systematic Review and Meta-Analysis.

Büyükkörük M., Şentürk A. F., Özger H. S.
Infectious diseases & clinical microbiology , vol.5, no.3, pp.188-197, 2023 (Peer-Reviewed Journal) Creative Commons License identifier

5. ENG: comparative evaluation of side effects and the factors affecting vaccıne preferences of healthcare workers within the booster Covid-19 vaccınation in turkey

YILDIZ Y., MAVİ H. M., Sultanova F., BÜYÜKKÖRÜK M., ÖZGER H. S., ŞENOL E.
Turkish Journal of Clinics and Laboratory , vol.14, 2023 (Peer-Reviewed Journal) identifier

6. Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study

YILDIZ Y., ÖZGER H. S., ŞENOL E., KARAKUŞ R., BÜYÜKKÖRÜK M., ALTIN F. B., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.122, pp.99-106, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

7. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress

KÜÇÜKKARAPINAR M., Yay-Pence A., YILDIZ Y., BÜYÜKKÖRÜK M., YAZ AYDIN G., Deveci-Bulut T. S., et al.
JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8, pp.1077-1089, 2022 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

8. Prognostic Value of Serial Measurement of Serum Des-Arg(6)-Bradykinin Levels in Severe COVID-19 Patients

AYSERT YILDIZ P., ÖZGER H. S., YILDIZ Y., BÜYÜKKÖRÜK M., Yildiz M., Deveci-Bulut T. S., et al.
CLINICAL LABORATORY , vol.68, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

9. Evaluation of prevalance and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients

Erbay K., Özger H. S., Güzel Tunçcan Ö., Gaygısız Ü., Büyükkörük M., Sultanova F., et al.
Antimicrobial Stewardship & Healthcare Epidemiology , vol.2, no.30, pp.1-7, 2022 (Peer-Reviewed Journal) Creative Commons License Sustainable Development identifier identifier

10. Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia

Yıldız M., Sultanova F., Özger H. S., Büyükkörük M., Erbay K., Gaygusuz Ü., et al.
Infectious diseases and clinical microbiology (Online) , vol.3, no.2, pp.55-63, 2021 (ESCI) Sustainable Development identifier identifier

11. Relationship Between COVID-19 Clinical Severity and Serum 25(OH)D Levels

ÖZGER H. S., AYSERT YILDIZ P., Tombul N., YILDIZ M., YILDIZ Y., BÜYÜKKÖRÜK M., et al.
MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , vol.10, 2021 (ESCI) Sustainable Development identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 6

1. Incidence rate of fungal secondary infections in COVID-19 patients; retrospective data of infection control committee in a Turkish university hospital

Muftah H., Erganiş S., Şahin E. A., Öztürk E., Demir F., Büyükkoruk M., et al.
TIMM, Athens, Greece, 20 - 23 October 2023, pp.276, (Summary Text) Creative Commons License

2. Evaluation of Antibody Kinetics in Healthcare Workers (HCWs) of an Istutition in Turkey, Vaccinated With Inactivated COVID-19 Vaccine

YILDIZ Y., ÖZGER H. S., ŞENOL E., KARAKUŞ R., BÜYÜKKÖRÜK M., Altın F., et al.
32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), Barcelona, Spain, 23 April 2022, (Full Text)

3. Evaluation of antibody kinetics in healthcare workers (HCWs) of an instutition in Turkey, vaccinated with inactivated COVID-19 vaccine

Yıldız Y., Özger H. S., Şenol E., Karakuş R., Büyükkörük M., Altın F. B., et al.
32nd ECCMID, Lisbon, Portugal, 23 - 26 April 2022, (Full Text) Creative Commons License Sustainable Development

4. Evaluation of antibody kinetics in healthcare workers (HCWs) of an institution in Turkey, vaccinated with inactivated COVID-19 vaccine"

Yıldız Y., Özger H. S., Şenol E., Karakuş R., Büyükkörük M., Altın F. B., et al.
32nd ECCMID, Lisbon, Portugal, 23 - 26 April 2022, pp.1, (Summary Text) Sustainable Development

5. Serum Neopterin Düzeylerinin Seri Ölçümünün Ağır COVID-19 Hastalarında Prognostik Değeri Var mı?

YILDIZ Y., ÖZGER H. S., BÜYÜKKÖRÜK M., YILDIZ M., ÇAĞLAR K., HIZEL K., et al.
22. Türk Klinik Mikrobiyoloji ve Enfeksiyon Hastalıkları Kongresi, Antalya, Turkey, 9 - 12 March 2022, (Full Text)

6. THE PROCESS OF SARS-COV-2 PCR POSITIVITY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

Altay Koçak A., Güzel Tunçcan Ö., Büyükkoruk M., Dikyar A. A., Sarzhanova S., Özkurt Z. N., et al.
ESCV, 15 - 17 September 2021, pp.126, (Full Text) Sustainable Development
Metrics

Publication

18

Publication (WoS)

7

Publication (Scopus)

7

Citation (WoS)

26

H-Index (WoS)

2

Citation (Scopus)

29

H-Index (Scopus)

3

Citation (Scholar)

4

H-Index (Scholar)

1

Project

2

Open Access

4
UN Sustainable Development Goals